Showing results (31-40 of 431) with videos related to
Sort By:
Pageof 44
Pharmacogenomics|December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposureLauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.Breast Cancer Research and Treatment|March 14, 2020
Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathyTheodore S Jennaro, Fang Fang, Kelley M Kidwell, et al.Transactions of the American Clinical and Climatological Association|September 3, 2015
Personalized Medicine: Genomics Trials in OncologyDaniel F Hayes, Anne F SchottSeminars in Oncology|June 14, 2002
c-erbB-2 in breast cancer: development of a clinically useful markerDaniel F Hayes, Ann D ThorCurrent Treatment Options in Oncology|May 2, 2015
Indications for prognostic gene expression profiling in early breast cancerErin F Cobain, Daniel F HayesClinical Chemistry|January 4, 2024
Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future ProspectsAndi K Cani, Daniel F HayesProgress in Molecular Biology and Translational Science|November 16, 2010
Circulating tumor cellsDaniel F Hayes, Jeffrey B SmerageJournal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?Daniel F Hayes, Anne F SchottOncology (Williston Park, N.Y.)|December 18, 2007
Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancerN Lynn Henry, Daniel F HayesPageof 44